EDGE MEDICAL-B (02675) Surges Over 7% Again, Surgical Robot Commercialization Expected to Enter Acceleration Phase

Stock News01-22

Following a substantial surge of over 11% yesterday, EDGE MEDICAL-B (02675) has climbed more than 7% again. At the time of writing, the stock was up 7.34%, trading at HK$70.95, with a turnover of HK$48.1849 million. On the news front, the National Healthcare Security Administration recently issued the "Guidelines for the Establishment of Price Items for Surgical and Therapeutic Auxiliary Operation Medical Services (Trial)", which establishes a unified national pricing framework for innovative medical technologies such as surgical robots, specialized consumables for energy devices, and remote surgery. China Post Securities believes that this nationally unified fee structure for robotic surgery will serve as a critical turning point for the commercialization of the surgical robot industry. According to a Northeast Securities research report, EDGE MEDICAL is one of the top two domestic surgical robot companies, with its multi-port, single-port, and natural orifice腔镜 robots rapidly gaining volume both domestically and internationally; the company ranked first among domestic players in the number of中标 for domestic腔镜 robot tenders in 2025. Its remote surgery modality received NMPA approval in November 2025 and achieved a milestone of 500 procedures in October 2025.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1139126147?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-01-22 15:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1139126147","market":"fut","top_or_hot":-1,"title":"EDGE MEDICAL-B (02675) Surges Over 7% Again, Surgical Robot Commercialization Expected to Enter Acceleration Phase","media":"Stock News","content":"<p>Following a substantial surge of over 11% yesterday, EDGE MEDICAL-B (02675) has climbed more than 7% again. At the time of writing, the stock was up 7.34%, trading at HK$70.95, with a turnover of HK$48.1849 million. On the news front, the National Healthcare Security Administration recently issued the \"Guidelines for the Establishment of Price Items for Surgical and Therapeutic Auxiliary Operation Medical Services (Trial)\", which establishes a unified national pricing framework for innovative medical technologies such as surgical robots, specialized consumables for energy devices, and remote surgery. China Post Securities believes that this nationally unified fee structure for robotic surgery will serve as a critical turning point for the commercialization of the surgical robot industry. According to a Northeast Securities research report, EDGE MEDICAL is one of the top two domestic surgical robot companies, with its multi-port, single-port, and natural orifice腔镜 robots rapidly gaining volume both domestically and internationally; the company ranked first among domestic players in the number of中标 for domestic腔镜 robot tenders in 2025. Its remote surgery modality received NMPA approval in November 2025 and achieved a milestone of 500 procedures in October 2025.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>EDGE MEDICAL-B (02675) Surges Over 7% Again, Surgical Robot Commercialization Expected to Enter Acceleration Phase</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEDGE MEDICAL-B (02675) Surges Over 7% Again, Surgical Robot Commercialization Expected to Enter Acceleration Phase\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036600163\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock News </p>\n<p class=\"h-time\">2026-01-22 15:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Following a substantial surge of over 11% yesterday, EDGE MEDICAL-B (02675) has climbed more than 7% again. At the time of writing, the stock was up 7.34%, trading at HK$70.95, with a turnover of HK$48.1849 million. On the news front, the National Healthcare Security Administration recently issued the \"Guidelines for the Establishment of Price Items for Surgical and Therapeutic Auxiliary Operation Medical Services (Trial)\", which establishes a unified national pricing framework for innovative medical technologies such as surgical robots, specialized consumables for energy devices, and remote surgery. China Post Securities believes that this nationally unified fee structure for robotic surgery will serve as a critical turning point for the commercialization of the surgical robot industry. According to a Northeast Securities research report, EDGE MEDICAL is one of the top two domestic surgical robot companies, with its multi-port, single-port, and natural orifice腔镜 robots rapidly gaining volume both domestically and internationally; the company ranked first among domestic players in the number of中标 for domestic腔镜 robot tenders in 2025. Its remote surgery modality received NMPA approval in November 2025 and achieved a milestone of 500 procedures in October 2025.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK1610","symbol_name":"ETF&股票定投概念","start_time":0,"source_url":"","article_id":"1139126147","we_media_id":"1036600163","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1139126147","pubTimestamp":1769067536,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Stock News","introduction":"Global Stock News First-Time Broadcast","home_visible":1,"id":"1036600163","head_image":"https://community-static.tradeup.com/news/b3bf6d02ad1a6e9e7377eebbb162346a"},"summary":"Following a substantial surge of over 11% yesterday, EDGE MEDICAL-B (02675) has climbed more than 7% again. At the time of writing, the stock was up 7.34%, trading at HK$70.95, with a turnover of...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"BK1610":"ETF&股票定投概念","02675":"精锋医疗-B","02800":"盈富基金"},"translate_title":"锐际医疗-B(02675)再度大涨超7%手术机器人商业化有望进入加速阶段","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02800":1,"02675":1},"content_text":"Following a substantial surge of over 11% yesterday, EDGE MEDICAL-B (02675) has climbed more than 7% again. At the time of writing, the stock was up 7.34%, trading at HK$70.95, with a turnover of HK$48.1849 million. On the news front, the National Healthcare Security Administration recently issued the \"Guidelines for the Establishment of Price Items for Surgical and Therapeutic Auxiliary Operation Medical Services (Trial)\", which establishes a unified national pricing framework for innovative medical technologies such as surgical robots, specialized consumables for energy devices, and remote surgery. China Post Securities believes that this nationally unified fee structure for robotic surgery will serve as a critical turning point for the commercialization of the surgical robot industry. According to a Northeast Securities research report, EDGE MEDICAL is one of the top two domestic surgical robot companies, with its multi-port, single-port, and natural orifice腔镜 robots rapidly gaining volume both domestically and internationally; the company ranked first among domestic players in the number of中标 for domestic腔镜 robot tenders in 2025. Its remote surgery modality received NMPA approval in November 2025 and achieved a milestone of 500 procedures in October 2025.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"productRelease","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1139126147","isCrawlerRequest":true}